Tag: Lord Mancroft

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government how many hepatitis C patients NHS England is planning to treat in 2016–17.

Lord Prior of Brampton

NHS England is planning to treat 10,000 patients with chronic hepatitis C in 2016/2017.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government for what reason NHS England intends to treat only a specified number of patients in 2016–17, as defined by recently published run rates for operational delivery networks services.

Lord Prior of Brampton

The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.

NHS England is funding providers to double the number of patients treated and this number will ensure the National Health Service fully meets in 2016/17 the patient numbers NICE set out for progressive rollout of the treatments at the time it published its guidance.

NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.

In meeting the obligations of its Mandate, NHS England has set out a planning approach for hepatitis C that delivers access to NICE recommended treatment without disinvestment in other health services.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government how many people diagnosed with hepatitis C are eligible for treatment under the National Institute for Health and Care Excellence guidance for new direct acting antiviral drugs.

Lord Prior of Brampton

Based on National Institute for Health and Care Excellence (NICE) modelling, NHS England has planned for 10,000 patients to be treated in 2016/17. No national registry exists for hepatitis C and as a result NICE estimates that the NHS should be treating 10,000 people based on the total number of people diagnosed with hepatitis C, their genotype, their treatment history and their disease severity, all of which impact on treatment eligibility.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government what plans they have to review their hepatitis C strategy in the light of other European countries’ strategies for tackling hepatitis C.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2015-12-16.

To ask Her Majesty’s Government when the national framework for hepatitis C, due for release in spring 2015, will be published, and why it has been delayed.

Lord Prior of Brampton

A date for publication of the hepatitis C improvement framework has not yet been set. Public Health England continues working with NHS England and Operational Delivery Networks (ODNs) to establish a process of monitoring hepatitis C treatment access and uptake.

Following their establishment in August 2015, ODNs will need to continue to be developed as a mechanism for ensuring equitable access to expert multidisciplinary team care and treatment for hepatitis C. ODNs are working to develop their plans, based on the published service specification and with the support of local specialised commissioning teams and regional clinical directors of specialised commissioning. Work is also underway to establish by February 2016 a national network of ODN clinical leads to share good practice. In addition, the draft hepatitis C improvement framework includes a number of areas pertinent to ODN operation and will therefore support further development of their role.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government whether plans to introduce a hepatitis C improvement framework have been abandoned and, if so, why.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2015-12-16.

To ask Her Majesty’s Government what steps they are taking to ensure that NHS England and Public Health England provide data demonstrating that there is equitable access to the new hepatitis C treatment.

Lord Prior of Brampton

Public Health England is working with NHS England and the Clinical Leads of the Operational Delivery Networks to ensure that a minimum data set is collected to allow monitoring of patients being treated. Limited demographic information will be requested to help interpret this information in the context of the whole infected population to help assess whether treatment access is as equitable as possible.

The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.

Lord Prior of Brampton

NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

The below Parliamentary question was asked by Lord Mancroft on 2015-12-16.

To ask Her Majesty’s Government how they plan to measure the effectiveness of the implementation of the new medicines for hepatitis C treatment, and when they will publish those results.

Lord Prior of Brampton

NHS England has advised that it is working with Public Health England and the clinical leads of the operational delivery networks to agree a common dataset which will enable the effectiveness of new medicines for hepatitis C to be measured.